nodes	percent_of_prediction	percent_of_DWPC	metapath
Atorvastatin—UGT2B7—Mycophenolic acid—psoriasis	0.0753	0.0801	CbGbCtD
Atorvastatin—UGT1A1—Mycophenolic acid—psoriasis	0.0651	0.0692	CbGbCtD
Atorvastatin—SLCO1B3—Mycophenolate mofetil—psoriasis	0.0432	0.046	CbGbCtD
Atorvastatin—UGT2B7—Mycophenolate mofetil—psoriasis	0.0421	0.0447	CbGbCtD
Atorvastatin—UGT1A1—Mycophenolate mofetil—psoriasis	0.0364	0.0387	CbGbCtD
Atorvastatin—CYP2C8—Tazarotene—psoriasis	0.0288	0.0306	CbGbCtD
Atorvastatin—CYP3A5—Beclomethasone—psoriasis	0.0278	0.0296	CbGbCtD
Atorvastatin—SLCO1B1—Mycophenolate mofetil—psoriasis	0.0252	0.0268	CbGbCtD
Atorvastatin—ABCC1—Cyclosporine—psoriasis	0.0226	0.0241	CbGbCtD
Atorvastatin—SLCO1A2—Prednisolone—psoriasis	0.0226	0.024	CbGbCtD
Atorvastatin—ABCC2—Mycophenolate mofetil—psoriasis	0.0221	0.0235	CbGbCtD
Atorvastatin—SLCO1A2—Hydrocortisone—psoriasis	0.0214	0.0228	CbGbCtD
Atorvastatin—SLCO1A2—Prednisone—psoriasis	0.0213	0.0227	CbGbCtD
Atorvastatin—SLCO1A2—Cyclosporine—psoriasis	0.0202	0.0215	CbGbCtD
Atorvastatin—SLCO1B1—Cyclosporine—psoriasis	0.0191	0.0203	CbGbCtD
Atorvastatin—SLCO1B3—Methotrexate—psoriasis	0.0173	0.0184	CbGbCtD
Atorvastatin—ABCC2—Cyclosporine—psoriasis	0.0168	0.0178	CbGbCtD
Atorvastatin—CYP2B6—Cholecalciferol—psoriasis	0.0162	0.0172	CbGbCtD
Atorvastatin—ABCC4—Methotrexate—psoriasis	0.0149	0.0159	CbGbCtD
Atorvastatin—SLCO1A2—Dexamethasone—psoriasis	0.0133	0.0142	CbGbCtD
Atorvastatin—CYP2D6—Hydroxyurea—psoriasis	0.0129	0.0138	CbGbCtD
Atorvastatin—CYP2C8—Cholecalciferol—psoriasis	0.0123	0.0131	CbGbCtD
Atorvastatin—ABCC1—Methotrexate—psoriasis	0.012	0.0127	CbGbCtD
Atorvastatin—CYP3A7—Hydrocortisone—psoriasis	0.0119	0.0126	CbGbCtD
Atorvastatin—CYP3A7-CYP3A51P—Hydrocortisone—psoriasis	0.0119	0.0126	CbGbCtD
Atorvastatin—CYP3A7-CYP3A51P—Cyclosporine—psoriasis	0.0112	0.0119	CbGbCtD
Atorvastatin—CYP3A7—Cyclosporine—psoriasis	0.0112	0.0119	CbGbCtD
Atorvastatin—CYP3A5—Mycophenolate mofetil—psoriasis	0.0111	0.0118	CbGbCtD
Atorvastatin—ABCC2—Dexamethasone—psoriasis	0.011	0.0117	CbGbCtD
Atorvastatin—SLCO1A2—Methotrexate—psoriasis	0.0107	0.0114	CbGbCtD
Atorvastatin—CYP2C8—Mycophenolate mofetil—psoriasis	0.0107	0.0113	CbGbCtD
Atorvastatin—CYP2C19—Cholecalciferol—psoriasis	0.0103	0.011	CbGbCtD
Atorvastatin—SLCO1B1—Methotrexate—psoriasis	0.0101	0.0107	CbGbCtD
Atorvastatin—CYP3A4—Calcitriol—psoriasis	0.00967	0.0103	CbGbCtD
Atorvastatin—CYP3A5—Hydrocortisone—psoriasis	0.00889	0.00945	CbGbCtD
Atorvastatin—ABCC2—Methotrexate—psoriasis	0.00887	0.00943	CbGbCtD
Atorvastatin—CYP2C9—Cholecalciferol—psoriasis	0.00857	0.00911	CbGbCtD
Atorvastatin—CYP2C8—Hydrocortisone—psoriasis	0.00855	0.00909	CbGbCtD
Atorvastatin—CYP3A5—Cyclosporine—psoriasis	0.0084	0.00893	CbGbCtD
Atorvastatin—CYP2C8—Cyclosporine—psoriasis	0.00807	0.00858	CbGbCtD
Atorvastatin—CYP2D6—Cholecalciferol—psoriasis	0.00783	0.00833	CbGbCtD
Atorvastatin—CYP3A4—Methoxsalen—psoriasis	0.00752	0.008	CbGbCtD
Atorvastatin—CYP3A7—Dexamethasone—psoriasis	0.00737	0.00784	CbGbCtD
Atorvastatin—CYP3A7-CYP3A51P—Dexamethasone—psoriasis	0.00737	0.00784	CbGbCtD
Atorvastatin—ABCB1—Mycophenolate mofetil—psoriasis	0.00721	0.00767	CbGbCtD
Atorvastatin—CYP2C19—Prednisone—psoriasis	0.00714	0.0076	CbGbCtD
Atorvastatin—CYP2B6—Dexamethasone—psoriasis	0.00702	0.00746	CbGbCtD
Atorvastatin—CYP2C19—Cyclosporine—psoriasis	0.00677	0.0072	CbGbCtD
Atorvastatin—ABCB1—Betamethasone—psoriasis	0.00619	0.00658	CbGbCtD
Atorvastatin—ABCB1—Prednisolone—psoriasis	0.0061	0.00649	CbGbCtD
Atorvastatin—ABCB1—Hydrocortisone—psoriasis	0.00579	0.00615	CbGbCtD
Atorvastatin—ABCB1—Prednisone—psoriasis	0.00576	0.00613	CbGbCtD
Atorvastatin—CYP2C9—Cyclosporine—psoriasis	0.00563	0.00599	CbGbCtD
Atorvastatin—CYP3A5—Dexamethasone—psoriasis	0.00553	0.00588	CbGbCtD
Atorvastatin—ABCB1—Cyclosporine—psoriasis	0.00546	0.00581	CbGbCtD
Atorvastatin—CYP2C8—Dexamethasone—psoriasis	0.00532	0.00565	CbGbCtD
Atorvastatin—CYP2D6—Cyclosporine—psoriasis	0.00515	0.00547	CbGbCtD
Atorvastatin—CYP3A4—Cholecalciferol—psoriasis	0.00498	0.0053	CbGbCtD
Atorvastatin—CYP2C19—Dexamethasone—psoriasis	0.00446	0.00474	CbGbCtD
Atorvastatin—CYP3A4—Triamcinolone—psoriasis	0.00432	0.00459	CbGbCtD
Atorvastatin—CYP3A4—Mycophenolate mofetil—psoriasis	0.00432	0.00459	CbGbCtD
Atorvastatin—CYP2C9—Dexamethasone—psoriasis	0.00371	0.00394	CbGbCtD
Atorvastatin—CYP3A4—Betamethasone—psoriasis	0.00371	0.00394	CbGbCtD
Atorvastatin—CYP3A4—Prednisolone—psoriasis	0.00366	0.00389	CbGbCtD
Atorvastatin—ABCB1—Dexamethasone—psoriasis	0.0036	0.00383	CbGbCtD
Atorvastatin—CYP3A4—Hydrocortisone—psoriasis	0.00347	0.00369	CbGbCtD
Atorvastatin—CYP3A4—Prednisone—psoriasis	0.00345	0.00367	CbGbCtD
Atorvastatin—CYP2D6—Dexamethasone—psoriasis	0.00339	0.00361	CbGbCtD
Atorvastatin—CYP3A4—Cyclosporine—psoriasis	0.00327	0.00348	CbGbCtD
Atorvastatin—ABCB1—Methotrexate—psoriasis	0.00289	0.00308	CbGbCtD
Atorvastatin—CYP3A4—Dexamethasone—psoriasis	0.00216	0.00229	CbGbCtD
Atorvastatin—CYP3A4—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.00016	0.00268	CbGpPWpGaD
Atorvastatin—CYP2C8—Biological oxidations—CYP2S1—psoriasis	0.000158	0.00265	CbGpPWpGaD
Atorvastatin—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000158	0.00264	CbGpPWpGaD
Atorvastatin—CYP2C8—Metapathway biotransformation—CYP2S1—psoriasis	0.000156	0.00261	CbGpPWpGaD
Atorvastatin—AHR—Adipogenesis—STAT3—psoriasis	0.000156	0.00261	CbGpPWpGaD
Atorvastatin—HMGCR—PPARA activates gene expression—PPARG—psoriasis	0.000155	0.0026	CbGpPWpGaD
Atorvastatin—AHR—Integrated Breast Cancer Pathway—NFKB1—psoriasis	0.000154	0.00258	CbGpPWpGaD
Atorvastatin—ABCB1—HIF-1-alpha transcription factor network—CP—psoriasis	0.000152	0.00254	CbGpPWpGaD
Atorvastatin—HMGCR—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—psoriasis	0.000152	0.00254	CbGpPWpGaD
Atorvastatin—SLCO1B3—SLC-mediated transmembrane transport—CP—psoriasis	0.000151	0.00252	CbGpPWpGaD
Atorvastatin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000147	0.00246	CbGpPWpGaD
Atorvastatin—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	0.000144	0.00241	CbGpPWpGaD
Atorvastatin—CYP2C19—Biological oxidations—CYP2S1—psoriasis	0.000141	0.00236	CbGpPWpGaD
Atorvastatin—AHR—Integrated Breast Cancer Pathway—VEGFA—psoriasis	0.00014	0.00234	CbGpPWpGaD
Atorvastatin—CYP2C19—Metapathway biotransformation—CYP2S1—psoriasis	0.000139	0.00233	CbGpPWpGaD
Atorvastatin—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000139	0.00233	CbGpPWpGaD
Atorvastatin—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000137	0.0023	CbGpPWpGaD
Atorvastatin—CYP2C19—Melatonin metabolism and effects—APOE—psoriasis	0.000137	0.00229	CbGpPWpGaD
Atorvastatin—AHR—Adipogenesis—TNF—psoriasis	0.000135	0.00226	CbGpPWpGaD
Atorvastatin—UGT1A3—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	0.000135	0.00226	CbGpPWpGaD
Atorvastatin—CYP2D6—Biological oxidations—CYP2S1—psoriasis	0.00013	0.00217	CbGpPWpGaD
Atorvastatin—CYP2C9—Biological oxidations—CYP2S1—psoriasis	0.000129	0.00216	CbGpPWpGaD
Atorvastatin—CYP2D6—Metapathway biotransformation—CYP2S1—psoriasis	0.000128	0.00214	CbGpPWpGaD
Atorvastatin—AHR—Circadian rythm related genes—JUN—psoriasis	0.000127	0.00213	CbGpPWpGaD
Atorvastatin—CYP2C9—Metapathway biotransformation—CYP2S1—psoriasis	0.000127	0.00213	CbGpPWpGaD
Atorvastatin—CYP2D6—Melatonin metabolism and effects—APOE—psoriasis	0.000126	0.00211	CbGpPWpGaD
Atorvastatin—UGT1A1—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	0.000124	0.00208	CbGpPWpGaD
Atorvastatin—ABCC4—Fluoropyrimidine Activity—TP53—psoriasis	0.000124	0.00207	CbGpPWpGaD
Atorvastatin—SLCO1A2—SLC-mediated transmembrane transport—CP—psoriasis	0.000118	0.00198	CbGpPWpGaD
Atorvastatin—ABCB1—Allograft Rejection—HLA-C—psoriasis	0.000117	0.00196	CbGpPWpGaD
Atorvastatin—ABCB1—Allograft Rejection—IL13—psoriasis	0.000116	0.00195	CbGpPWpGaD
Atorvastatin—AHR—Adipogenesis—IL6—psoriasis	0.000109	0.00182	CbGpPWpGaD
Atorvastatin—HMGCR—Metabolism—NDUFA5—psoriasis	0.000107	0.0018	CbGpPWpGaD
Atorvastatin—ABCB1—Allograft Rejection—IL17A—psoriasis	0.000107	0.00179	CbGpPWpGaD
Atorvastatin—AHR—Integrated Breast Cancer Pathway—TP53—psoriasis	0.000105	0.00177	CbGpPWpGaD
Atorvastatin—HMGCR—AMPK Signaling—TP53—psoriasis	0.000105	0.00176	CbGpPWpGaD
Atorvastatin—HMGCR—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—psoriasis	0.000104	0.00175	CbGpPWpGaD
Atorvastatin—DPP4—Metabolism of proteins—ACE—psoriasis	0.000103	0.00173	CbGpPWpGaD
Atorvastatin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000102	0.00172	CbGpPWpGaD
Atorvastatin—SLCO1B1—SLC-mediated transmembrane transport—CP—psoriasis	0.000101	0.00169	CbGpPWpGaD
Atorvastatin—ABCC5—Metabolism—NDUFA5—psoriasis	0.000101	0.00169	CbGpPWpGaD
Atorvastatin—HMGCR—Metabolism of lipids and lipoproteins—CARM1—psoriasis	0.0001	0.00167	CbGpPWpGaD
Atorvastatin—ABCB1—Allograft Rejection—IL12B—psoriasis	9.96e-05	0.00167	CbGpPWpGaD
Atorvastatin—SLCO2B1—Transmembrane transport of small molecules—CP—psoriasis	9.8e-05	0.00164	CbGpPWpGaD
Atorvastatin—ABCB1—Allograft Rejection—HLA-E—psoriasis	9.72e-05	0.00163	CbGpPWpGaD
Atorvastatin—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	9.57e-05	0.0016	CbGpPWpGaD
Atorvastatin—ABCC5—Transmembrane transport of small molecules—CP—psoriasis	9.37e-05	0.00157	CbGpPWpGaD
Atorvastatin—SLCO2B1—Transmembrane transport of small molecules—CARM1—psoriasis	9.35e-05	0.00157	CbGpPWpGaD
Atorvastatin—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	9.31e-05	0.00156	CbGpPWpGaD
Atorvastatin—HMGCR—Metabolism—CYP2S1—psoriasis	9.12e-05	0.00153	CbGpPWpGaD
Atorvastatin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	9.05e-05	0.00152	CbGpPWpGaD
Atorvastatin—ABCC5—Transmembrane transport of small molecules—CARM1—psoriasis	8.94e-05	0.0015	CbGpPWpGaD
Atorvastatin—UGT1A3—Metabolism—NDUFA5—psoriasis	8.74e-05	0.00146	CbGpPWpGaD
Atorvastatin—ABCC5—Metabolism—CYP2S1—psoriasis	8.57e-05	0.00144	CbGpPWpGaD
Atorvastatin—HMGCR—Integrated Breast Cancer Pathway—JUN—psoriasis	8.53e-05	0.00143	CbGpPWpGaD
Atorvastatin—CYP3A4—Biological oxidations—CYP2S1—psoriasis	8.48e-05	0.00142	CbGpPWpGaD
Atorvastatin—AHR—Circadian rythm related genes—TP53—psoriasis	8.39e-05	0.0014	CbGpPWpGaD
Atorvastatin—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	8.37e-05	0.0014	CbGpPWpGaD
Atorvastatin—SLCO1B3—Metabolism—NDUFA5—psoriasis	8.24e-05	0.00138	CbGpPWpGaD
Atorvastatin—HMGCR—Integrated Breast Cancer Pathway—NFKB1—psoriasis	8.21e-05	0.00138	CbGpPWpGaD
Atorvastatin—CYP2C19—Melatonin metabolism and effects—NFKB1—psoriasis	8.14e-05	0.00136	CbGpPWpGaD
Atorvastatin—ABCC4—Platelet degranulation—VEGFA—psoriasis	8.07e-05	0.00135	CbGpPWpGaD
Atorvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	8.04e-05	0.00135	CbGpPWpGaD
Atorvastatin—ABCC4—Hemostasis—ITGAL—psoriasis	7.77e-05	0.0013	CbGpPWpGaD
Atorvastatin—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—psoriasis	7.69e-05	0.00129	CbGpPWpGaD
Atorvastatin—SLCO1B3—Metabolism of lipids and lipoproteins—CARM1—psoriasis	7.68e-05	0.00129	CbGpPWpGaD
Atorvastatin—AHR—Circadian rythm related genes—IL6—psoriasis	7.68e-05	0.00129	CbGpPWpGaD
Atorvastatin—SLCO1B3—Transmembrane transport of small molecules—CP—psoriasis	7.65e-05	0.00128	CbGpPWpGaD
Atorvastatin—CYP2D6—Melatonin metabolism and effects—NFKB1—psoriasis	7.48e-05	0.00125	CbGpPWpGaD
Atorvastatin—HMGCR—Integrated Breast Cancer Pathway—VEGFA—psoriasis	7.45e-05	0.00125	CbGpPWpGaD
Atorvastatin—UGT2B7—Metabolism—NDUFA5—psoriasis	7.43e-05	0.00124	CbGpPWpGaD
Atorvastatin—UGT1A3—Metabolism—CYP2S1—psoriasis	7.43e-05	0.00124	CbGpPWpGaD
Atorvastatin—CYP3A4—Tryptophan metabolism—CAT—psoriasis	7.32e-05	0.00123	CbGpPWpGaD
Atorvastatin—SLCO1B3—Transmembrane transport of small molecules—CARM1—psoriasis	7.3e-05	0.00122	CbGpPWpGaD
Atorvastatin—ABCB1—Allograft Rejection—IL10—psoriasis	7.28e-05	0.00122	CbGpPWpGaD
Atorvastatin—ABCB1—Allograft Rejection—IL4—psoriasis	7.08e-05	0.00119	CbGpPWpGaD
Atorvastatin—SLCO1B3—Metabolism—CYP2S1—psoriasis	7e-05	0.00117	CbGpPWpGaD
Atorvastatin—ABCB1—Allograft Rejection—HLA-B—psoriasis	6.92e-05	0.00116	CbGpPWpGaD
Atorvastatin—ABCB1—HIF-1-alpha transcription factor network—LEP—psoriasis	6.92e-05	0.00116	CbGpPWpGaD
Atorvastatin—ABCC4—Transmembrane transport of small molecules—CP—psoriasis	6.49e-05	0.00109	CbGpPWpGaD
Atorvastatin—SLCO1A2—Metabolism—NDUFA5—psoriasis	6.47e-05	0.00108	CbGpPWpGaD
Atorvastatin—ABCB1—HIF-1-alpha transcription factor network—NOS2—psoriasis	6.44e-05	0.00108	CbGpPWpGaD
Atorvastatin—ABCB1—Allograft Rejection—HLA-A—psoriasis	6.42e-05	0.00107	CbGpPWpGaD
Atorvastatin—DPP4—Metabolism of proteins—LEP—psoriasis	6.41e-05	0.00107	CbGpPWpGaD
Atorvastatin—UGT2B7—Metabolism—CYP2S1—psoriasis	6.32e-05	0.00106	CbGpPWpGaD
Atorvastatin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	6.31e-05	0.00106	CbGpPWpGaD
Atorvastatin—ABCC4—Transmembrane transport of small molecules—CARM1—psoriasis	6.19e-05	0.00104	CbGpPWpGaD
Atorvastatin—UGT1A1—Metabolism—NDUFA5—psoriasis	6.04e-05	0.00101	CbGpPWpGaD
Atorvastatin—SLCO1A2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	6.03e-05	0.00101	CbGpPWpGaD
Atorvastatin—SLCO1A2—Transmembrane transport of small molecules—CP—psoriasis	6.01e-05	0.00101	CbGpPWpGaD
Atorvastatin—ABCB1—Allograft Rejection—HLA-DRB1—psoriasis	5.86e-05	0.000982	CbGpPWpGaD
Atorvastatin—ABCC1—Metabolism—NDUFA5—psoriasis	5.82e-05	0.000975	CbGpPWpGaD
Atorvastatin—SLCO1A2—Transmembrane transport of small molecules—CARM1—psoriasis	5.74e-05	0.000961	CbGpPWpGaD
Atorvastatin—HMGCR—Integrated Breast Cancer Pathway—TP53—psoriasis	5.63e-05	0.000943	CbGpPWpGaD
Atorvastatin—SLCO1B1—Metabolism—NDUFA5—psoriasis	5.53e-05	0.000927	CbGpPWpGaD
Atorvastatin—SLCO1A2—Metabolism—CYP2S1—psoriasis	5.5e-05	0.000922	CbGpPWpGaD
Atorvastatin—ABCC2—Transmembrane transport of small molecules—CP—psoriasis	5.47e-05	0.000917	CbGpPWpGaD
Atorvastatin—ABCC1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	5.43e-05	0.000909	CbGpPWpGaD
Atorvastatin—ABCC1—Transmembrane transport of small molecules—CP—psoriasis	5.41e-05	0.000906	CbGpPWpGaD
Atorvastatin—ABCC2—Transmembrane transport of small molecules—CARM1—psoriasis	5.22e-05	0.000875	CbGpPWpGaD
Atorvastatin—ABCC1—Transmembrane transport of small molecules—CARM1—psoriasis	5.16e-05	0.000865	CbGpPWpGaD
Atorvastatin—SLCO1B1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	5.16e-05	0.000864	CbGpPWpGaD
Atorvastatin—SLCO1B1—Transmembrane transport of small molecules—CP—psoriasis	5.14e-05	0.000861	CbGpPWpGaD
Atorvastatin—UGT1A1—Metabolism—CYP2S1—psoriasis	5.13e-05	0.00086	CbGpPWpGaD
Atorvastatin—CYP3A7—Metabolism—NDUFA5—psoriasis	5.08e-05	0.000851	CbGpPWpGaD
Atorvastatin—ABCC1—Metabolism—CYP2S1—psoriasis	4.95e-05	0.000829	CbGpPWpGaD
Atorvastatin—SLCO1B1—Transmembrane transport of small molecules—CARM1—psoriasis	4.91e-05	0.000822	CbGpPWpGaD
Atorvastatin—HMGCR—Metabolism of lipids and lipoproteins—APOE—psoriasis	4.78e-05	0.0008	CbGpPWpGaD
Atorvastatin—SLCO1B1—Metabolism—CYP2S1—psoriasis	4.7e-05	0.000788	CbGpPWpGaD
Atorvastatin—HMGCR—Metabolism—CARM1—psoriasis	4.45e-05	0.000746	CbGpPWpGaD
Atorvastatin—CYP3A7—Metabolism—CYP2S1—psoriasis	4.32e-05	0.000723	CbGpPWpGaD
Atorvastatin—ABCB1—Allograft Rejection—IFNG—psoriasis	4.28e-05	0.000717	CbGpPWpGaD
Atorvastatin—ABCB1—HIF-1-alpha transcription factor network—JUN—psoriasis	4.27e-05	0.000716	CbGpPWpGaD
Atorvastatin—DPP4—Metabolism of proteins—CXCL8—psoriasis	4.26e-05	0.000713	CbGpPWpGaD
Atorvastatin—ABCC5—Metabolism—CARM1—psoriasis	4.19e-05	0.000701	CbGpPWpGaD
Atorvastatin—HMGCR—Metabolism of lipids and lipoproteins—PPARG—psoriasis	4.16e-05	0.000697	CbGpPWpGaD
Atorvastatin—ABCB1—Allograft Rejection—CXCL8—psoriasis	3.98e-05	0.000667	CbGpPWpGaD
Atorvastatin—CYP2B6—Metabolism—NDUFA5—psoriasis	3.76e-05	0.000629	CbGpPWpGaD
Atorvastatin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—psoriasis	3.73e-05	0.000625	CbGpPWpGaD
Atorvastatin—CYP3A5—Metabolism—NDUFA5—psoriasis	3.67e-05	0.000615	CbGpPWpGaD
Atorvastatin—SLCO1B3—Metabolism of lipids and lipoproteins—APOE—psoriasis	3.67e-05	0.000615	CbGpPWpGaD
Atorvastatin—UGT1A3—Metabolism—CARM1—psoriasis	3.63e-05	0.000608	CbGpPWpGaD
Atorvastatin—ABCC4—Platelet activation, signaling and aggregation—VEGFA—psoriasis	3.58e-05	0.0006	CbGpPWpGaD
Atorvastatin—SLCO1B3—Metabolism—CARM1—psoriasis	3.42e-05	0.000573	CbGpPWpGaD
Atorvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	3.28e-05	0.000549	CbGpPWpGaD
Atorvastatin—ABCB1—Allograft Rejection—VEGFA—psoriasis	3.23e-05	0.000542	CbGpPWpGaD
Atorvastatin—SLCO1B3—Metabolism of lipids and lipoproteins—PPARG—psoriasis	3.2e-05	0.000535	CbGpPWpGaD
Atorvastatin—CYP2B6—Metabolism—CYP2S1—psoriasis	3.19e-05	0.000535	CbGpPWpGaD
Atorvastatin—ABCC4—Hemostasis—NOS2—psoriasis	3.19e-05	0.000534	CbGpPWpGaD
Atorvastatin—CYP2C8—Metabolism—NDUFA5—psoriasis	3.18e-05	0.000533	CbGpPWpGaD
Atorvastatin—CYP3A5—Metabolism—CYP2S1—psoriasis	3.12e-05	0.000523	CbGpPWpGaD
Atorvastatin—UGT2B7—Metabolism—CARM1—psoriasis	3.09e-05	0.000517	CbGpPWpGaD
Atorvastatin—CYP2C8—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.96e-05	0.000497	CbGpPWpGaD
Atorvastatin—SLCO1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.88e-05	0.000483	CbGpPWpGaD
Atorvastatin—CYP2C19—Metabolism—NDUFA5—psoriasis	2.84e-05	0.000475	CbGpPWpGaD
Atorvastatin—ABCB1—Allograft Rejection—TNF—psoriasis	2.77e-05	0.000464	CbGpPWpGaD
Atorvastatin—ABCB1—Metabolism—NDUFA5—psoriasis	2.77e-05	0.000464	CbGpPWpGaD
Atorvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	2.75e-05	0.000461	CbGpPWpGaD
Atorvastatin—HMGCR—Metabolism—CAT—psoriasis	2.74e-05	0.000459	CbGpPWpGaD
Atorvastatin—CYP2C8—Metabolism—CYP2S1—psoriasis	2.7e-05	0.000453	CbGpPWpGaD
Atorvastatin—SLCO1A2—Metabolism—CARM1—psoriasis	2.69e-05	0.00045	CbGpPWpGaD
Atorvastatin—CYP2C19—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.65e-05	0.000443	CbGpPWpGaD
Atorvastatin—CYP2D6—Metabolism—NDUFA5—psoriasis	2.61e-05	0.000437	CbGpPWpGaD
Atorvastatin—ABCC1—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.59e-05	0.000435	CbGpPWpGaD
Atorvastatin—CYP2C9—Metabolism—NDUFA5—psoriasis	2.59e-05	0.000433	CbGpPWpGaD
Atorvastatin—ABCC5—Metabolism—CAT—psoriasis	2.57e-05	0.000431	CbGpPWpGaD
Atorvastatin—ABCB1—Transmembrane transport of small molecules—CP—psoriasis	2.57e-05	0.000431	CbGpPWpGaD
Atorvastatin—ABCC5—Disease—HLA-A—psoriasis	2.56e-05	0.000429	CbGpPWpGaD
Atorvastatin—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.51e-05	0.000421	CbGpPWpGaD
Atorvastatin—UGT1A1—Metabolism—CARM1—psoriasis	2.51e-05	0.00042	CbGpPWpGaD
Atorvastatin—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.47e-05	0.000413	CbGpPWpGaD
Atorvastatin—ABCB1—Transmembrane transport of small molecules—CARM1—psoriasis	2.46e-05	0.000411	CbGpPWpGaD
Atorvastatin—ABCC1—Metabolism—CARM1—psoriasis	2.42e-05	0.000405	CbGpPWpGaD
Atorvastatin—CYP2C19—Metabolism—CYP2S1—psoriasis	2.41e-05	0.000404	CbGpPWpGaD
Atorvastatin—CYP2C9—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.41e-05	0.000404	CbGpPWpGaD
Atorvastatin—ABCC5—Disease—APOE—psoriasis	2.39e-05	0.0004	CbGpPWpGaD
Atorvastatin—ABCB1—Metabolism—CYP2S1—psoriasis	2.36e-05	0.000394	CbGpPWpGaD
Atorvastatin—SLCO1B1—Metabolism—CARM1—psoriasis	2.3e-05	0.000385	CbGpPWpGaD
Atorvastatin—ABCC1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.26e-05	0.000379	CbGpPWpGaD
Atorvastatin—UGT1A3—Metabolism—CAT—psoriasis	2.23e-05	0.000374	CbGpPWpGaD
Atorvastatin—ABCC5—Disease—NOS2—psoriasis	2.23e-05	0.000373	CbGpPWpGaD
Atorvastatin—CYP2D6—Metabolism—CYP2S1—psoriasis	2.22e-05	0.000372	CbGpPWpGaD
Atorvastatin—CYP2C9—Metabolism—CYP2S1—psoriasis	2.2e-05	0.000369	CbGpPWpGaD
Atorvastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.15e-05	0.00036	CbGpPWpGaD
Atorvastatin—HMGCR—Metabolism—APOE—psoriasis	2.13e-05	0.000356	CbGpPWpGaD
Atorvastatin—CYP3A7—Metabolism—CARM1—psoriasis	2.11e-05	0.000353	CbGpPWpGaD
Atorvastatin—SLCO1B3—Metabolism—CAT—psoriasis	2.1e-05	0.000352	CbGpPWpGaD
Atorvastatin—ABCC5—Metabolism—APOE—psoriasis	2e-05	0.000335	CbGpPWpGaD
Atorvastatin—UGT2B7—Metabolism—CAT—psoriasis	1.9e-05	0.000318	CbGpPWpGaD
Atorvastatin—HMGCR—Metabolism—PPARG—psoriasis	1.85e-05	0.00031	CbGpPWpGaD
Atorvastatin—ABCC4—Hemostasis—VEGFA—psoriasis	1.85e-05	0.000309	CbGpPWpGaD
Atorvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	1.83e-05	0.000306	CbGpPWpGaD
Atorvastatin—ABCC5—Disease—TYK2—psoriasis	1.82e-05	0.000305	CbGpPWpGaD
Atorvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	1.76e-05	0.000294	CbGpPWpGaD
Atorvastatin—ABCC5—Metabolism—PPARG—psoriasis	1.74e-05	0.000292	CbGpPWpGaD
Atorvastatin—UGT1A3—Metabolism—APOE—psoriasis	1.73e-05	0.00029	CbGpPWpGaD
Atorvastatin—CYP3A4—Metabolism—NDUFA5—psoriasis	1.71e-05	0.000286	CbGpPWpGaD
Atorvastatin—SLCO1A2—Metabolism—CAT—psoriasis	1.65e-05	0.000277	CbGpPWpGaD
Atorvastatin—ABCC5—Disease—CD4—psoriasis	1.65e-05	0.000276	CbGpPWpGaD
Atorvastatin—SLCO1B3—Metabolism—APOE—psoriasis	1.63e-05	0.000274	CbGpPWpGaD
Atorvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	1.6e-05	0.000267	CbGpPWpGaD
Atorvastatin—CYP2B6—Metabolism—CARM1—psoriasis	1.56e-05	0.000261	CbGpPWpGaD
Atorvastatin—UGT1A1—Metabolism—CAT—psoriasis	1.54e-05	0.000258	CbGpPWpGaD
Atorvastatin—CYP3A5—Metabolism—CARM1—psoriasis	1.52e-05	0.000255	CbGpPWpGaD
Atorvastatin—UGT1A3—Metabolism—PPARG—psoriasis	1.51e-05	0.000253	CbGpPWpGaD
Atorvastatin—ABCC1—Metabolism—CAT—psoriasis	1.49e-05	0.000249	CbGpPWpGaD
Atorvastatin—ABCC1—Disease—HLA-A—psoriasis	1.48e-05	0.000248	CbGpPWpGaD
Atorvastatin—UGT2B7—Metabolism—APOE—psoriasis	1.47e-05	0.000247	CbGpPWpGaD
Atorvastatin—CYP3A4—Metabolism—CYP2S1—psoriasis	1.45e-05	0.000243	CbGpPWpGaD
Atorvastatin—SLCO1B3—Metabolism—PPARG—psoriasis	1.42e-05	0.000238	CbGpPWpGaD
Atorvastatin—CYP2C8—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.42e-05	0.000237	CbGpPWpGaD
Atorvastatin—SLCO1B1—Metabolism—CAT—psoriasis	1.41e-05	0.000237	CbGpPWpGaD
Atorvastatin—ABCC4—Hemostasis—TP53—psoriasis	1.39e-05	0.000234	CbGpPWpGaD
Atorvastatin—ABCC1—Disease—APOE—psoriasis	1.38e-05	0.000231	CbGpPWpGaD
Atorvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	1.37e-05	0.000229	CbGpPWpGaD
Atorvastatin—CYP2C8—Metabolism—CARM1—psoriasis	1.32e-05	0.000221	CbGpPWpGaD
Atorvastatin—CYP3A7—Metabolism—CAT—psoriasis	1.3e-05	0.000217	CbGpPWpGaD
Atorvastatin—ABCC1—Disease—NOS2—psoriasis	1.29e-05	0.000215	CbGpPWpGaD
Atorvastatin—UGT2B7—Metabolism—PPARG—psoriasis	1.28e-05	0.000215	CbGpPWpGaD
Atorvastatin—SLCO1A2—Metabolism—APOE—psoriasis	1.28e-05	0.000215	CbGpPWpGaD
Atorvastatin—ABCC5—Disease—STAT3—psoriasis	1.28e-05	0.000214	CbGpPWpGaD
Atorvastatin—CYP2C19—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.26e-05	0.000212	CbGpPWpGaD
Atorvastatin—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.23e-05	0.000207	CbGpPWpGaD
Atorvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	1.21e-05	0.000202	CbGpPWpGaD
Atorvastatin—UGT1A1—Metabolism—APOE—psoriasis	1.2e-05	0.000201	CbGpPWpGaD
Atorvastatin—CYP2C19—Metabolism—CARM1—psoriasis	1.18e-05	0.000197	CbGpPWpGaD
Atorvastatin—ABCC1—Metabolism—APOE—psoriasis	1.16e-05	0.000194	CbGpPWpGaD
Atorvastatin—CYP2C9—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.15e-05	0.000193	CbGpPWpGaD
Atorvastatin—ABCB1—Metabolism—CARM1—psoriasis	1.15e-05	0.000193	CbGpPWpGaD
Atorvastatin—SLCO1A2—Metabolism—PPARG—psoriasis	1.12e-05	0.000187	CbGpPWpGaD
Atorvastatin—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.1e-05	0.000184	CbGpPWpGaD
Atorvastatin—SLCO1B1—Metabolism—APOE—psoriasis	1.1e-05	0.000184	CbGpPWpGaD
Atorvastatin—CYP2D6—Metabolism—CARM1—psoriasis	1.08e-05	0.000182	CbGpPWpGaD
Atorvastatin—CYP2C9—Metabolism—CARM1—psoriasis	1.07e-05	0.00018	CbGpPWpGaD
Atorvastatin—ABCC1—Disease—TYK2—psoriasis	1.05e-05	0.000176	CbGpPWpGaD
Atorvastatin—UGT1A1—Metabolism—PPARG—psoriasis	1.04e-05	0.000175	CbGpPWpGaD
Atorvastatin—CYP3A7—Metabolism—APOE—psoriasis	1.01e-05	0.000169	CbGpPWpGaD
Atorvastatin—ABCC1—Metabolism—PPARG—psoriasis	1.01e-05	0.000169	CbGpPWpGaD
Atorvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1e-05	0.000168	CbGpPWpGaD
Atorvastatin—CYP2B6—Metabolism—CAT—psoriasis	9.59e-06	0.000161	CbGpPWpGaD
Atorvastatin—SLCO1B1—Metabolism—PPARG—psoriasis	9.56e-06	0.00016	CbGpPWpGaD
Atorvastatin—ABCC1—Disease—CD4—psoriasis	9.52e-06	0.00016	CbGpPWpGaD
Atorvastatin—CYP3A5—Metabolism—CAT—psoriasis	9.38e-06	0.000157	CbGpPWpGaD
Atorvastatin—ABCC5—Disease—IL6—psoriasis	8.92e-06	0.000149	CbGpPWpGaD
Atorvastatin—CYP3A7—Metabolism—PPARG—psoriasis	8.78e-06	0.000147	CbGpPWpGaD
Atorvastatin—CYP2C8—Metabolism—CAT—psoriasis	8.12e-06	0.000136	CbGpPWpGaD
Atorvastatin—CYP2B6—Metabolism—APOE—psoriasis	7.45e-06	0.000125	CbGpPWpGaD
Atorvastatin—ABCC1—Disease—STAT3—psoriasis	7.37e-06	0.000124	CbGpPWpGaD
Atorvastatin—CYP3A5—Metabolism—APOE—psoriasis	7.28e-06	0.000122	CbGpPWpGaD
Atorvastatin—CYP2C19—Metabolism—CAT—psoriasis	7.25e-06	0.000121	CbGpPWpGaD
Atorvastatin—CYP3A4—Metabolism—CARM1—psoriasis	7.09e-06	0.000119	CbGpPWpGaD
Atorvastatin—ABCB1—Metabolism—CAT—psoriasis	7.07e-06	0.000118	CbGpPWpGaD
Atorvastatin—CYP2D6—Metabolism—CAT—psoriasis	6.67e-06	0.000112	CbGpPWpGaD
Atorvastatin—CYP2C9—Metabolism—CAT—psoriasis	6.61e-06	0.000111	CbGpPWpGaD
Atorvastatin—CYP2B6—Metabolism—PPARG—psoriasis	6.49e-06	0.000109	CbGpPWpGaD
Atorvastatin—CYP3A5—Metabolism—PPARG—psoriasis	6.35e-06	0.000106	CbGpPWpGaD
Atorvastatin—CYP2C8—Metabolism—APOE—psoriasis	6.31e-06	0.000106	CbGpPWpGaD
Atorvastatin—CYP2C19—Metabolism—APOE—psoriasis	5.63e-06	9.43e-05	CbGpPWpGaD
Atorvastatin—ABCB1—Metabolism—APOE—psoriasis	5.5e-06	9.21e-05	CbGpPWpGaD
Atorvastatin—CYP2C8—Metabolism—PPARG—psoriasis	5.5e-06	9.21e-05	CbGpPWpGaD
Atorvastatin—CYP2D6—Metabolism—APOE—psoriasis	5.18e-06	8.68e-05	CbGpPWpGaD
Atorvastatin—ABCC1—Disease—IL6—psoriasis	5.15e-06	8.63e-05	CbGpPWpGaD
Atorvastatin—CYP2C9—Metabolism—APOE—psoriasis	5.14e-06	8.6e-05	CbGpPWpGaD
Atorvastatin—CYP2C19—Metabolism—PPARG—psoriasis	4.91e-06	8.22e-05	CbGpPWpGaD
Atorvastatin—ABCB1—Metabolism—PPARG—psoriasis	4.79e-06	8.02e-05	CbGpPWpGaD
Atorvastatin—CYP2D6—Metabolism—PPARG—psoriasis	4.51e-06	7.56e-05	CbGpPWpGaD
Atorvastatin—CYP2C9—Metabolism—PPARG—psoriasis	4.47e-06	7.49e-05	CbGpPWpGaD
Atorvastatin—CYP3A4—Metabolism—CAT—psoriasis	4.36e-06	7.3e-05	CbGpPWpGaD
Atorvastatin—CYP3A4—Metabolism—APOE—psoriasis	3.39e-06	5.67e-05	CbGpPWpGaD
Atorvastatin—CYP3A4—Metabolism—PPARG—psoriasis	2.95e-06	4.94e-05	CbGpPWpGaD
